108 related articles for article (PubMed ID: 8339280)
1. Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases.
Lindblom A; Rotstein S; Skoog L; Nordenskjöld M; Larsson C
Cancer Res; 1993 Aug; 53(16):3707-11. PubMed ID: 8339280
[TBL] [Abstract][Full Text] [Related]
2. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
[TBL] [Abstract][Full Text] [Related]
3. Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer.
Hansen LL; Yilmaz M; Overgaard J; Andersen J; Kruse TA
Cancer Res; 1998 May; 58(10):2166-9. PubMed ID: 9605761
[TBL] [Abstract][Full Text] [Related]
4. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread.
Tsuda H; Callen DF; Fukutomi T; Nakamura Y; Hirohashi S
Cancer Res; 1994 Jan; 54(2):513-7. PubMed ID: 8275489
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity accumulation in primary breast carcinomas and additionally in corresponding distant metastases is associated with poor outcome.
Hampl M; Hampl JA; Reiss G; Schackert G; Saeger HD; Schackert HK
Clin Cancer Res; 1999 Jun; 5(6):1417-25. PubMed ID: 10389927
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis.
Winqvist R; Hampton GM; Mannermaa A; Blanco G; Alavaikko M; Kiviniemi H; Taskinen PJ; Evans GA; Wright FA; Newsham I
Cancer Res; 1995 Jun; 55(12):2660-4. PubMed ID: 7780982
[TBL] [Abstract][Full Text] [Related]
7. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.
Sato T; Tanigami A; Yamakawa K; Akiyama F; Kasumi F; Sakamoto G; Nakamura Y
Cancer Res; 1990 Nov; 50(22):7184-9. PubMed ID: 1977515
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion.
Noviello C; Courjal F; Theillet C
Clin Cancer Res; 1996 Sep; 2(9):1601-6. PubMed ID: 9816339
[TBL] [Abstract][Full Text] [Related]
9. Location of several putative genes possibly involved in human breast cancer progression.
Driouch K; Briffod M; Bièche I; Champème MH; Lidereau R
Cancer Res; 1998 May; 58(10):2081-6. PubMed ID: 9605747
[TBL] [Abstract][Full Text] [Related]
10. Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer.
Cleton-Jansen AM; Buerger H; Haar Nt; Philippo K; van de Vijver MJ; Boecker W; Smit VT; Cornelisse CJ
Genes Chromosomes Cancer; 2004 Oct; 41(2):109-16. PubMed ID: 15287023
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic significance of loss of heterozygosity in breast cancer].
Iwase H; Iwata H; Toyama T; Hara Y; Omoto Y; Kobayashi S
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():426-30. PubMed ID: 9589047
[TBL] [Abstract][Full Text] [Related]
12. Identification of multiple breast cancers of multicentric origin by histological observations and distribution of allele loss on chromosome 16q.
Tsuda H; Hirohashi S
Cancer Res; 1995 Aug; 55(15):3395-8. PubMed ID: 7614478
[TBL] [Abstract][Full Text] [Related]
13. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
[TBL] [Abstract][Full Text] [Related]
14. High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases.
Ree AH; Florenes VA; Berg JP; Maelandsmo GM; Nesland JM; Fodstad O
Clin Cancer Res; 1997 Sep; 3(9):1623-8. PubMed ID: 9815852
[TBL] [Abstract][Full Text] [Related]
15. Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas.
Utada Y; Haga S; Kajiwara T; Kasumi F; Sakamoto G; Nakamura Y; Emi M
Cancer; 2000 Mar; 88(6):1410-6. PubMed ID: 10717624
[TBL] [Abstract][Full Text] [Related]
16. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
17. HER2 gene status in primary breast cancers and matched distant metastases.
Tapia C; Savic S; Wagner U; Schönegg R; Novotny H; Grilli B; Herzog M; Barascud AD; Zlobec I; Cathomas G; Terracciano L; Feichter G; Bubendorf L
Breast Cancer Res; 2007; 9(3):R31. PubMed ID: 17511881
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity on chromosome 6p21.2 as a potential marker for recurrence after radiotherapy of human cervical cancer.
Harima Y; Harima K; Sawada S; Tanaka Y; Arita S; Ohnishi T
Clin Cancer Res; 2000 Mar; 6(3):1079-85. PubMed ID: 10741737
[TBL] [Abstract][Full Text] [Related]
19. DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer.
Dellas A; Torhorst J; Schultheiss E; Mihatsch MJ; Moch H
Clin Cancer Res; 2002 May; 8(5):1210-6. PubMed ID: 12006540
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity in familial breast carcinomas.
Lindblom A; Skoog L; Rotstein S; Werelius B; Larsson C; Nordenskjöld M
Cancer Res; 1993 Sep; 53(18):4356-61. PubMed ID: 8364930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
